Register | Forgot password?
Switch to Arabic
Wednesday, November 11 - 2009
Page navigation Browse related articles

ICLDC's experts on stage at Primary Healthcare Conference 2008

  • United Arab Emirates: Monday, October 27 - 2008 at 12:40
  • PRESS RELEASE

Incretin therapy signals a new era for Diabetes treatment and management, according to Karim Meeran, Professor of Endocrinology and Lead Clinician, Imperial College London.

Article continues below
 
He was speaking at the opening day of the Primary Healthcare Congress 2008 (Abu Dhabi National Healthcare Centre, October 26-28, 2008).

Professor Meeran suggested that the treatment of hyperglycaemia, or high sugar levels, must start with the simple steps of adopting a balanced diet and embarking upon a regular exercise regime.

However, he warned that some mainstream treatments actually increase appetite and this has led to overweight patients gaining even more weight.

Professor Meeran said:
"Incretin therapy introduces an incretin hormone, GLP-1, which can be used on its own or with insulin. It is known to help normalise blood sugar levels by increasing the insulin produced by the pancreas, at the same time decreasing the release of glucagons."


"Findings show that this generally promotes a feeling of fullness after eating a meal, thus suppressing the need to eat more," Professor Meeran explained.

One of the UAE's leading voices in the management, treatment and prevention of Diabetes, Dr Maha Taysir Barakat, confirmed that it is becoming increasingly clear that the epidemic of type 2 Diabetes is associated with decreasing levels of activity and an increasing prevalence of obesity.

Dr Maha was chairing the session on metabolic syndrome and associated diseases.

She said that research has revealed the more than 80% of people with type 2 Diabetes are obese or overweight.

She added, "Obesity has reached alarming proportions in the Middle East. Women and children feature prominently in this rise with more than 45% of women in the 15-49 age groups identified as overweight or even obese."

"Likewise, there has been a staggering increase of type 2 Diabetes in younger people in the UAE. Children as young as ten are being diagnosed with the disease, many due to obesity driven by physical inactivity and unhealthy diet," she added.

Dr Maha, the Medical & Research Director and Consultant Endocrinologist at Abu Dhabi's Imperial College London Diabetes Centre, agrees that exercise is a vital component in prevention of Diabetes, and not just diet alone.

"It is proven that a brisk walk for 30 minutes a day, five days a week can reduce the risk of developing Diabetes by 58 percent," she said.

Diabetes and Cardiovascular disease: A fatal combination



ICLDC's Consultant Cardiologist, Dr Jenes Peder Bagger is set to chair at the day three session on Cardiovascular Disease.

Dr Bagger, an international expert in heart disease and other metabolic conditions, noted that many people are unaware of the increased risks to the heart that are associated with Diabetes.

He said that, like Diabetes, the symptoms of cardiovascular disease (CVD) may go undetected and untreated for years.

"Most people with CVD do not feel pain or experience any notable early symptoms. This results in around 5% of Diabetes patients suffering what we call a silent heart attack. This is likely to cause damage to the heart and could also lead to sudden death," he added.

Research shows that both men and women are at equal risk of developing Diabetes, a disease currently estimated to affect more than 19.5% of the adult UAE population and predicted to increase to 21.5% by 2025.

Dr. Bagger warned that CVD in people with Diabetes is two to six times higher than in people without. This means that the risk of a sudden death related to CVD is consistently greater among patients living with Diabetes.

He further confirmed that research continues to look for the cause or causes of Diabetes and in particular the associated higher risks of heart disease.

"We are constantly looking at methods to effectively manage, prevent, and even reverse CVD associated with Diabetes," he confirmed.
Also consider reading:
Log in to request more information from ICLDC

Notes and media contacts

About Imperial College London Diabetes Centre:

The Imperial College London Diabetes Centre is a state-of-the-art specialised out-patient one-stop facility that specialises in Diabetes Treatment, Research, Training and Public Health. Located in Abu Dhabi (next to the Zayed Military Hospital), ICLDC allows the highest level of specialised patient care, from first diagnosis to the continued management of all complications associated with Diabetes.

Imperial College London holds a renowned history and expertise in the study of Diabetes, bringing one of the leading medical academic institutions in the world to Abu Dhabi as a core working partner. Under ICLDC practices, one of the Centre's primary objectives will be to provide continuing education for health professionals and the general public.

For media enquiries:

Anu Bhatnagar
Strategic Solutions for ICLDC
Tel: + 9714 3903018

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions